Newsletter
Hyperlipidemia

Mayo Clinic Talks

Hyperlipidemia

Guest: Monique A. Freund, M.D. Host: Darryl S. Chutka, M.D. (@ChutkaMD) Hyperlipidemia is one of the major risk factors for cardiovascular disease. It’s known that a combination of lifestyle changes…
November 16, 2021
ADVERTISEMENT
COPD Podcast by Health Unmuted

Hyperlipidemia

Guest: Monique A. Freund, M.D.

Host: Darryl S. Chutka, M.D. (@ChutkaMD)

Hyperlipidemia is one of the major risk factors for cardiovascular disease. It’s known that a combination of lifestyle changes and pharmacologic therapy has proven effective in reducing the complications of cardiovascular disease. Despite this, it’s estimated that less than 35% of those patients with hyperlipidemia are adequately managed. Why aren’t we doing a better job at managing this major public health problem? In this podcast, we’ll be speaking with Monique A. Freund, M.D., a cardiologist at Mayo Clinic. We’ll discuss how to optimize management of hyperlipidemia, which lifestyle changes are beneficial, when to use pharmacologic therapy and how to manage patients with statin intolerance.

Specific topics:

  • Relative importance of elevated LDLc, low HDLc and elevated triglycerides
  • Effective non-pharmacologic therapy for treating elevated LDLc, low HDLc and elevated triglycerides
  • When to consider starting a patient on a statin
  • Benefits of fish oil
  • Mechanism of action of statins
  • Statin intolerance
  • When to use ezetimibe
  • When to use one of the PCSK9-inhibitors

Connect with the Mayo Clinic’s School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

ADVERTISEMENT
COPD Podcast by Health Unmuted

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
November is COPD Awareness Month! COPD affects millions of people in the US and around the world. Tune into this new podcast miniseries to learn more!